Senior Director, Scientific Innovation, Oncology
Stefan Hart is the Senior Director of Oncology Scientific Innovation at Johnson & Johnson Innovation Center, Asia Pacific. In this role, he is responsible for identifying and leading opportunities on external innovation supporting the Oncology Therapeutic Area strategies.
Stefan has significant experience in the field of cancer biology, with more than 14 years in research and drug discovery environment across academia, biotech and pharma. worked at Roche Translational Medicine Hub as the Manager of Pre-clinical Academic Alliance where he was leading the pre-clinical oncology research strategy of the Hub to support immediate and mid-term organizational needs. Prior to that, he was a Senior Scientist at S*BIO Pte Ltd where he acted as a core member of Pracritinib drug development team. He led the pre-clinical development and successfully implemented the clinical biomarker strategy.
Stefan trained as an engineer in biotechnology at the University for Applied Sciences Weihenstephan (Freising, Germany). He received his Ph.D. research at the Max-Planck-Institute for Biochemistry, where his work focused on the transactivation of the EGFR by G protein-coupled receptors in human cancer, and resulted in significant publications that led to the MPIB Junior Research Award in 2004. Stefan did his postdoctoral research at the Institute for Medical Biology (IMB), Singapore where he launched the Singapore OncoGenome Project. Stefan is also the author of 25 publications in peer-reviewed scientific journals and of two patents